134 related articles for article (PubMed ID: 21203624)
1. The role of coordination chemistry in the development of copper and rhenium radiopharmaceuticals.
Donnelly PS
Dalton Trans; 2011 Feb; 40(5):999-1010. PubMed ID: 21203624
[TBL] [Abstract][Full Text] [Related]
2. Differences between the macroscopic and tracer level chemistry of rhenium and technetium: contrasting cage isomerisation behaviour of Re(I) and Tc(I) carborane complexes.
Armstrong AF; Valliant JF
Dalton Trans; 2010 Sep; 39(35):8128-31. PubMed ID: 20694253
[TBL] [Abstract][Full Text] [Related]
3. Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals.
Tisato F; Bolzati C; Porchia M; Refosco F
Mass Spectrom Rev; 2004; 23(5):309-32. PubMed ID: 15264232
[TBL] [Abstract][Full Text] [Related]
4. Rhenium diazenide ternary complexes with dithiocarbamate ligands: towards new rhenium radiopharmaceuticals.
Cowley AR; Dilworth JR; Donnelly PS; Ross SJ
Dalton Trans; 2007 Jan; (1):73-82. PubMed ID: 17160176
[TBL] [Abstract][Full Text] [Related]
5. One and two photon fluorescent complexes of rhenium and their technetium analogues.
Botchway S; Dilworth JR; Salichou M
Dalton Trans; 2010 Jun; 39(22):5219-20. PubMed ID: 20405059
[TBL] [Abstract][Full Text] [Related]
6. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions.
Lim JK; Mathias CJ; Green MA
J Med Chem; 1997 Jan; 40(1):132-6. PubMed ID: 9016338
[TBL] [Abstract][Full Text] [Related]
7. Towards new copper based radiopharmaceuticals.
Barnard P; Bayly S; Betts H; Bonnitcha P; Christlieb M; Dilworth J; Holland J; Pascu S
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):174-84. PubMed ID: 18354370
[TBL] [Abstract][Full Text] [Related]
8. Photoexcitation in Cu(I) and Re(I) complexes containing substituted dipyrido[3,2-a:2',3'-c]phenazine: a spectroscopic and density functional theoretical study.
Walsh PJ; Gordon KC; Lundin NJ; Blackman AG
J Phys Chem A; 2005 Jul; 109(26):5933-42. PubMed ID: 16833927
[TBL] [Abstract][Full Text] [Related]
9. Bifunctional chelators for copper radiopharmaceuticals: the synthesis of [Cu(ATSM)-amino acid] and [Cu(ATSM)-octreotide] conjugates.
Cowley AR; Dilworth JR; Donnelly PS; Heslop JM; Ratcliffe SJ
Dalton Trans; 2007 Jan; (2):209-17. PubMed ID: 17180189
[TBL] [Abstract][Full Text] [Related]
10. Mixed-ligand rhenium-188 complexes with tetradentate/monodentate NS3/P ('4 + 1') coordination: relation of structure with antioxidation stability.
Schiller E; Seifert S; Tisato F; Refosco F; Kraus W; Spies H; Pietzsch HJ
Bioconjug Chem; 2005; 16(3):634-43. PubMed ID: 15898732
[TBL] [Abstract][Full Text] [Related]
11. Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc).
Bowen ML; Lim NC; Ewart CB; Misri R; Ferreira CL; Häfeli U; Adam MJ; Orvig C
Dalton Trans; 2009 Nov; (42):9216-27. PubMed ID: 20449199
[TBL] [Abstract][Full Text] [Related]
12. A hexadentate bis(thiosemicarbazonato) ligand: rhenium(V), iron(III) and cobalt(III) complexes.
Paterson BM; White JM; Donnelly PS
Dalton Trans; 2010 Mar; 39(11):2831-7. PubMed ID: 20200709
[TBL] [Abstract][Full Text] [Related]
13. Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.
Tzanopoulou S; Pirmettis IC; Patsis G; Raptopoulou C; Terzis A; Papadopoulos M; Pelecanou M
Inorg Chem; 2006 Jan; 45(2):902-9. PubMed ID: 16411729
[TBL] [Abstract][Full Text] [Related]
14. Dithiocarbamate complexes as radiopharmaceuticals for medical imaging.
Berry DJ; Torres Martin de Rosales R; Charoenphun P; Blower PJ
Mini Rev Med Chem; 2012 Oct; 12(12):1174-83. PubMed ID: 22931590
[TBL] [Abstract][Full Text] [Related]
15. A mono-diazenide complex from perrhenate: toward a new core for rhenium radiopharmaceuticals.
Cowley AR; Dilworth JR; Donnelly PS
Inorg Chem; 2003 Feb; 42(4):929-31. PubMed ID: 12588118
[TBL] [Abstract][Full Text] [Related]
16. Microwave-assisted synthesis of 3,1,2- and 2,1,8-Re(I) and 99mTc(I)-metallocarborane complexes.
Green AE; Causey PW; Louie AS; Armstrong AF; Harrington LE; Valliant JF
Inorg Chem; 2006 Jul; 45(15):5727-9. PubMed ID: 16841972
[TBL] [Abstract][Full Text] [Related]
17. Radiometal complexes: characterization and relevant in vitro studies.
Jurisson S; Cutler C; Smith SV
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):222-34. PubMed ID: 18480740
[TBL] [Abstract][Full Text] [Related]
18. Pyridylthiocarbazide complexes of rhenium with potential radiopharmaceutical applications.
Clarke C; Cowley AR; Dilworth JR; Donnelly PS
Dalton Trans; 2004 Aug; (16):2402-3. PubMed ID: 15303150
[TBL] [Abstract][Full Text] [Related]
19. Copper complexes with dissymmetrically substituted bis(thiosemicarbazone) ligands as a basis for PET radiopharmaceuticals: control of redox potential and lipophilicity.
Brown OC; Baguña Torres J; Holt KB; Blower PJ; Went MJ
Dalton Trans; 2017 Oct; 46(42):14612-14630. PubMed ID: 28703233
[TBL] [Abstract][Full Text] [Related]
20. Assessment of macrocyclic triamine ligands as synthons for organometallic 99mTc radiopharmaceuticals.
Suzuki K; Shimmura N; Thipyapong K; Uehara T; Akizawa H; Arano Y
Inorg Chem; 2008 Apr; 47(7):2593-600. PubMed ID: 18269240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
